Thoracic Surgery Grand Rounds


June 15, 2016

7:30 am

Induction Chemotherapy for T3N0M0 Non-Small Cell Lung Cancer Confers Superior Rates of Complete Resection

Michael Mulvihill, MD

Research Fellow

Outcomes after Surgical Resection of Stage IV Non-Small Cell Lung Cancer

Babatunde Yerokum, MD

Research Fellow

Joint Accreditation Statement

In support of improving patient care, the Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Credit Designation Statement
Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Learning Objectives
At the conclusion of this activity, learners should be able to:

1. Review and discuss technical aspects of cardiothoracic surgery.

2. Discuss clinical research findings and advances in thoracic surgery.

3. Present and discuss case studies, protocols and treatment guidelines as appropriate to the thoracic surgery practice.

Summary of Faculty Disclosure/Planning Committee
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:  Michael Mulvihill, MD; and Babatunde Yerokun, MD.

Speaker Name: 
Michael Mulvhill, MD and Babatunde Yerokun, MD
Duke Medical Pavilion Durham, NC
Durham, NC
United States
Room Number: 
Session date: 
Wednesday, June 15, 2016 - 7:30am to 8:30am
  • 1.00 AMA PRA Category 1 Credit(s)

Please login or register to take this course.